Email Story

Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion

By Ciara Linnane, MarketWatch
Last Update: 6:05 AM ET Dec 29, 2020
** denotes Required Fields


Send this story to: **

Enter the e-mail address of the recipient. Separate multiple addresses with commas.

Add your own personal message:


Enter your e-mail address: **

Note: Your e-mail address, and that of your recipients, will be used only in the case of transmission errors and to let the recipient know who sent the story. The information will not be used for any other purpose.

Format: HTML Text-only

Verification keywords


Partner Center

Link to MarketWatch's Slice.